[S5] シンポジウム5「Genetic Diseases」

[S5-1] 低ホスファターゼ症に対する新規治療薬（遺伝子治療薬：ARU-2801）の有効性と安全性の検討

^○松本 多絵^1,2, Dongwei Zhao², 三宅 紀子³, Sonoko Narisawa⁴, Jos? Luis Mill?n⁴, Koichi Miyake² (1.日本医科大学小児科学, 2.日本医科大学遺伝子治療学, 3.日本医科大学生化学・分子生物学(分子遺伝学), 4.Sanford Children’s Health Research Center, Sanford-Burnham-Prebys Medical Discovery Institute, La Jolla, CA, USA)

キーワード：Hypophosphatasia gene therapy

 
 
 
Concurrent researcher, Department of Gene Therapy 2021-current 
Pediatrician, Nippon Medical School Tamanagayama hospital, Department of Pediatrics 2018-current 
Tokyo Yamate Medical Center, Department of Pediatrics 2015-2017 
Shizuoka Medical Center, Department of Pediatrics 2001-2003 
 
Senior Residency
2004      Kanagawa Children’s Medical Center, Emergency and intensive care department
 
Pediatrics Trainee
Japanese Red Cross Tokyo Katsushika Perinatal Center, NICU 2001
Nippon Medical School, Department of Pediatrics 1999-2001